Neuroscientists have been trying to understand how the brain processes visual information for over a century. The development ...

Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

(Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the publication of positive Phase 1 GARDian1 trial results for ...

A large international study 1 published in the British Journal of Ophthalmology has extended the knowledge about monkeypox ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...

A common parasitic infection, neurocysticercosis, is increasingly causing seizures in children, often mistaken for other ...

Your brain is constantly juggling information that arrives in a flash with thoughts that unfold over seconds, minutes, or ...

Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in ...

Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...

A 63-year-old man reported that objects -- especially people and faces -- began to appear much smaller than normally expected ...